Overview

Opioid Free Anesthesia in Bariatric Surgery

Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
0
Participant gender:
All
Summary
This study compares the intraoperative opioid free anesthesia approach in laparoscopic bariatric surgery to a conventional opioid- based anesthesia. Half of participants will receive opioid free anesthesia with dexmedetomidine, lidocaine and ketamine while the other half will receive opioid based anesthesia with fentanyl, remi-fentanyl and ketamine
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Lebanese American University
Treatments:
Analgesics, Opioid
Anesthetics
Dexmedetomidine
Fentanyl
Lidocaine
Remifentanil
Criteria
Inclusion Criteria:

- Age group: 18-65 years old

- American Society of Anesthesiologists (ASA )class I and II

- Indicated laparoscopic bariatric surgery

Exclusion Criteria:

- Renal, hepatic or cardiac insufficiency

- Positive pregnancy test

- Alcohol or drug abuse

- Psychiatric disease

- History of chronic pain

- Allergy or contraindication to any of the study drugs